{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:12Z","timestamp":1791237972561,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":4018,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1111\/j.0022-202x.2004.23448.x","type":"journal-article","created":{"date-parts":[[2004,11,18]],"date-time":"2004-11-18T14:19:49Z","timestamp":1100787589000},"page":"1037-1044","source":"Crossref","is-referenced-by-count":218,"title":["A Phase I Study Evaluating the Safety, Pharmacokinetics, and Clinical Response of a Human IL-12 p40 Antibody in Subjects with Plaque Psoriasis"],"prefix":"10.1016","volume":"123","author":[{"given":"Catharine L.","family":"Kauffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Aria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Toichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice B.","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Everitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Frederick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Pendley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Mascelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0010","series-title":"Cellular and Molecular Immunology","author":"Abbas","year":"2000"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0923-1811(91)90019-T","article-title":"Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction","volume":"2","author":"Barker","year":"1991","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1084\/jem.20031482","article-title":"Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-\u03b1","volume":"199","author":"Boyman","year":"2004","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0025","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.4049\/jimmunol.169.11.6554","article-title":"Prevention of experimental autoimmune encephalomyeletis in common marmosets using an anti-IL-12p40 monoclonal antibody","volume":"169","author":"Brok","year":"2002","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0030","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0035","series-title":"Dermatology in General Medicine","first-page":"489","article-title":"Psoriasis","author":"Christophers","year":"1993"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis-oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0050","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1001\/jama.290.23.3073","article-title":"Efalizumab for patients with moderate to severe plaque psoriasis: A randomized controlled trial","volume":"290","author":"Gordon","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0055","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/archderm.139.12.1627","article-title":"A randomized trial of etanercept as monotherapy for psoriasis","volume":"139","author":"Gottlieb","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0060","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199503023320907","article-title":"Treatment of psoriasis","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0065","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0733-8635(18)30038-X","article-title":"Immunopathogenesis and immunotherapy of psoriasis","volume":"13","author":"Griffiths","year":"1995","journal-title":"Dermatol Clin"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0070","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.4049\/jimmunol.162.12.7480","article-title":"IL-12, independently of IFN-\u03b3, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder","volume":"162","author":"Hong","year":"1999","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0075","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/bmj.300.6736.1398-c","article-title":"Psoriasis and bone marrow transplantation","volume":"300","author":"Jowitt","year":"1990","journal-title":"BMJ"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajh.10169","article-title":"Resolution of psoriasis following allogenic bone marrow transplantation for chronic myelogenous leukemia: Case report and review of the literature","volume":"71","author":"Kanamori","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0085","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.4049\/jimmunol.170.11.5438","article-title":"IL-23 production by cosecretion of endogenous p19 and transgenic p40 in keratin 14\/p40 transgenic mice: Evidence for enhanced cutaneous immunity","volume":"170","author":"Kopp","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0095","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMoa030002","article-title":"A novel targeted T-cell modulator, efalizumab, for plaque psoriasis","volume":"349","author":"Lebwohl","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","article-title":"Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris","volume":"199","author":"Lee","year":"2004","journal-title":"J Exp Med"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0105","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0110","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1067\/mjd.2001.117850","article-title":"The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody","volume":"45","author":"Papp","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.0022-202X.2004.23448.x_bb0125","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1046\/j.1523-1747.1998.00446.x","article-title":"Expression of interleukin-12 is increased in psoriatic skin","volume":"111","author":"Yawalkar","year":"1998","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15320595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15320595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,30]],"date-time":"2023-04-30T09:45:55Z","timestamp":1682847955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15320595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0022202X15320595"],"URL":"https:\/\/doi.org\/10.1111\/j.0022-202x.2004.23448.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}